Compare BANF & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANF | CRL |
|---|---|---|
| Founded | 1984 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 7.8B |
| IPO Year | N/A | 2000 |
| Metric | BANF | CRL |
|---|---|---|
| Price | $116.93 | $160.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $129.50 | ★ $205.27 |
| AVG Volume (30 Days) | 112.1K | ★ 854.2K |
| Earning Date | 01-22-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 10.40 | N/A |
| EPS | ★ 7.11 | N/A |
| Revenue | $684,958,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $6.10 | N/A |
| Revenue Next Year | $3.92 | $1.70 |
| P/E Ratio | $16.31 | ★ N/A |
| Revenue Growth | ★ 10.04 | N/A |
| 52 Week Low | $97.02 | $91.86 |
| 52 Week High | $138.77 | $228.88 |
| Indicator | BANF | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 24.30 |
| Support Level | $114.17 | $148.34 |
| Resistance Level | $122.21 | $218.69 |
| Average True Range (ATR) | 2.70 | 9.40 |
| MACD | 0.37 | -6.28 |
| Stochastic Oscillator | 61.13 | 16.17 |
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.